The Human Upgrade: Biohacking for Longevity & Performance

How Hacking Your Gut Bacteria Can Regulate Your Blood Sugar – Colleen Cutcliffe, Ph.D., with Dave Asprey : 767

Dec 4, 2020
Colleen Cutcliffe, Ph.D., CEO of Pendulum Therapeutics, discusses groundbreaking advancements in gut microbiome research. She reveals how Pendulum is developing probiotics specifically aimed at managing blood sugar levels, particularly for those with type 2 diabetes. Colleen shares insights from clinical trials and emphasizes the importance of gut health in overall well-being. The conversation also highlights the interconnectedness of microbiomes and innovative approaches towards improving metabolic health in a holistic manner.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Daughter's Health and Microbiome Research

  • Colleen Cutcliffe's daughter was born prematurely and received multiple doses of antibiotics.
  • This led to food sensitivities and metabolic issues, inspiring Cutcliffe to explore the microbiome's impact on health.
INSIGHT

Long-Read DNA Sequencing

  • Long-read DNA sequencing provides a more complete picture of the microbiome by analyzing longer DNA fragments.
  • This differs from short-read sequencing, which analyzes shorter fragments and can miss crucial information.
ADVICE

A1C Testing

  • Pendulum offers free A1C testing at baseline and three months into product use.
  • This helps users track their results and see the impact on their blood sugar management.
Get the Snipd Podcast app to discover more snips from this episode
Get the app